Becker's ASC Review

7 ASC MANAGEMENT Who leads Surgery Partners? 20 things to know By Laura Dyrda Nashville, Tenn.-based Surgery Partners is one of the largest ASC chains in the U.S. with more than 180 locations nationwide. It has around 4,000 affiliated physicians that serve more than 600,000 patients annually. e company has also produced around 10 percent same-facility growth in the past five years. Here are 20 things to know about the company's leadership team. Executive Chair of the Board: Wayne DeVeydt 1. Mr. DeVeydt became executive chair of the board in January aer spending two years as the company's CEO and director. 2. Prior to joining Surgery Partners, Mr. DeVeydt was vice presi- dent and CFO of Anthem for almost 10 years. During that time, he oversaw the company's financial operations. 3. In addition to his role at Surgery Partners, Mr. DeVeydt serves on the board of directors for NiSource and Myovant Sciences. 4. During his tenure, he led the company to nearly 8 percent same- facility revenue year-over-year in 2019 and built a new model for sustainable double-digit adjustable EBITDA growth. 5. In 2019, Mr. DeVeydt received $3.6 million in total compensation with base pay at $1.3 million, according to an SEC report high- lighted by Salary.com. CEO: Eric Evans 6. Mr. Evans became CEO and director of Surgery Partners in January aer spending less than a year as executive vice president and COO. 7. Mr. Evans was president of hospital operations at Dallas-based Tenet Healthcare before joining Surgery Partners. He also spent time as CEO of Tenet's Texas region. 8. He earned an MBA from Boston-based Harvard Business School. 9. In 2019, Mr. Evans earned $4.6 million in total compensation. His base pay was $435,157 and he received total equity of $3.9 million, according to an SEC report highlighted by Salary.com. 10. During his time as president of hospital operations at Tenet Healthcare, he oversaw 68 acute care hospitals and 161 hospital- affiliated facilities. CFO: Tom Cowhey 11. Mr. Cowhey is executive vice president and CFO of Surgery Partners, a position he has held since April 2018, when he joined the company. 12. Mr. Cowhey has previous experience in financial management roles at Aetna and was CFO of the company's institution business portfolio, which includes Aetna's health plan business. 13. His leadership was integral in Surgery Partners increasing revenues by 3.4 percent to $1.8 billion in 2019. In the first quarter of 2020, revenues were up 5.8 percent year-over-year to $441 million. 14. In 2019, Mr. Cowhey reported nearly $2.9 million in total compensation. He received $469,030 in base pay and more than $2 million in total equity, according to an SEC filed highlighted on Salary.com. 15. He earned an MBA from Duke University Fuqua School of Busi- ness in Durham, N.C. CAO: Jennifer Baldock 16. Ms. Baldock is executive vice president and chief administrative and development officer of Surgery Partners, a role she took on in February 2019 aer joining the company as executive vice president and general counsel. 17. Ms. Baldock previously served as general counsel and chief com- pliance officer of Symbion, which Surgery Partners acquired in 2014. 18. Ms. Baldock has experience as assistant general counsel for Ambulatory Services of America and Renal Care Group. 19. In 2019, Ms. Baldock received $1.8 million total compensa- tion, which includes $1.2 million in total equity. Her base pay was $440,481, according to an SEC filed highlighted on Salary.com. 20. She earned her JD from e University of Alabama in Tuscaloosa. n California surgery center owner, companion allegedly defrauded $51M+ from insurance companies By Eric Oliver B everly Hills, Calif.-based Wellness Wave surgical center owner Randy Rosen, MD, and his companion allegedly defrauded 18 insurance companies for more than $51 million, local NBC affiliate NBC 4 reports. Five things to know: 1. Dr. Rosen and co-defendant Liza Vismanos are being held on $52 million bail on charges alleging they ran an insurance fraud scheme. 2. In June 2017, Dr. Rosen and Ms. Vismanos allegedly targeted patients from addiction recovery rehabilita- tion clinics to implant a non-FDA-approved naltrexone implant and perform a series of cortisone injections. 3. Dr. Rosen allegedly put his patients under anes- thesia for the procedures to bill insurance and ran unnecessary blood and urine tests at a laboratory he also owned. 4. An investigation claims the pair billed 18 insur- ance companies from June 2017 to May 2019 for $661,940,464, receiving $51,060,523. 5. Investigators believe the pair used "body-broker" groups to send patients to the clinic in exchange for a portion of the insurance proceeds, and that at least 35 of Dr. Rosen's patients have died, many by overdose. n

• Cover